• Home >
  • Publications >
  • Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial

Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial

1 Nov 2019The Lancet Oncology

DOI : 10.1016/s1470-2045(19)30617-5

Authors

Gianni Bisogno, Gian Luca De Salvo, Christophe Bergeron, Soledad Gallego Melcón, Johannes H Merks, Anna Kelsey, Helene Martelli, Veronique Minard-Colin, Daniel Orbach, Heidi Glosli, Julia Chisholm, Michela Casanova, Ilaria Zanetti, Christine Devalck, Myriam Ben-Arush, Peter Mudry, Sima Ferman, Meriel Jenney, Andrea Ferrari